688065.SH上海证券交易所 · 科创板 STAR
Cathay Biotech 凯赛生物
Chemical Products 化学制品
¥38.34−¥0.98 · −2.49%
Open 开盘
¥39.28
High 最高
¥39.61
Low 最低
¥38.28
Prev Close 昨收
¥39.32
Volume 成交量
297.7万股
Turnover 成交额
¥1.15亿
Mkt Cap 总市值
¥277亿
P/E 市盈率
44.3×
Recent Activity 近期动态All Filings 全部公告 →
8 significant filings since 29 May 2026: 1 on litigation, 4 on equity incentive and 1 on guarantee or financial assistance, and 2 other kinds. The latest, on 24 Sep 2026: 上海市锦天城律师事务所关于上海凯赛生物技术股份有限公司2025年员工持股计划预留份额购买价格调整及分配的法律意见书.
自 29 May 2026 起有 8 份重大公告：litigation 1 份、equity incentive 4 份、guarantee or financial assistance 1 份，另有 2 类。最新一份（24 Sep 2026）：上海市锦天城律师事务所关于上海凯赛生物技术股份有限公司2025年员工持股计划预留份额购买价格调整及分配的法律意见书。
40.0045.0050.0055.0060.00
Volume 成交量
1,778.2万
Sep 25Dec 25Mar 26Jun 26Sep 26
Overview 概览Deep Report 深度报告Financials 财务Valuation 估值Ownership 股东Analysts 券商Estimates 预测News 动态Events 事件Peers 同业
Relative Value 同业比较
Chemical Products 化学制品 · 185 listed peers
| Measure 指标 | This Company 本公司 | Peer Median 同业中值 | Standing 排位 | |
|---|---|---|---|---|
| Market Cap 市值 | ¥277亿 | ¥46亿 | 9th highest of 185 · 185 家中第 9 高 | |
| Trailing P/E 市盈率 | 44.3x | 39.8x | 66th highest of 147 · 147 家中第 66 高 | |
| P/B 市净率 | 1.6x | 2.3x | 38th lowest of 185 · 185 家中第 38 低 | |
| Revenue Growth 营收增速 | 13.7% | 13.2% | 89th highest of 185 · 185 家中第 89 高 | |
| Profit Growth 净利增速 | 20.8% | 4.1% | 69th highest of 185 · 185 家中第 69 高 | |
| Gross Margin 毛利率 | 35.7% | 22.5% | 27th highest of 185 · 185 家中第 27 高 | |
| Net Margin 净利率 | 19.5% | 6.3% | 17th highest of 185 · 185 家中第 17 高 | |
| Return on Equity 净资产收益率 | 2.1% | 2.9% | 73rd lowest of 184 · 184 家中第 73 低 | |
| Debt to Assets 资产负债率 | 12.3% | 31.4% | 26th lowest of 185 · 185 家中第 26 低 | |
| Grade Score 评级得分 | 70 | 50 | 26th highest of 185 · 185 家中第 26 高 |
Statement figures are for the period to 30 Jun 2026, filed by 185 of 185 peers. A rank needs 5 or more peers with a value. A company with no earnings has no P/E. 报表数据为截至 30 Jun 2026 的期间，185 家同业中 185 家已披露。排位至少需要 5 家有数据的同业；无盈利的公司没有市盈率。
Largest Peers 主要同业
| Peer 同业 | Market Cap | P/E | P/B | Revenue Growth | Net Margin | ROE | Grade |
|---|---|---|---|---|---|---|---|
| Wanhua 万华化学 | ¥2,174亿 | 13.2x | 1.9x | 31.3% | 9.7% | 9.0% | C |
| Zhejiang Juhua 巨化股份 | ¥917亿 | 20.9x | 4.2x | 0.1% | 22.3% | 12.2% | C |
| Zhejiang NHU 新和成 | ¥790亿 | 11.0x | 2.3x | 18.3% | 30.7% | 11.4% | C |
| Haohua Chemical Science & Technology 昊华科技 | ¥582亿 | 34.2x | 3.1x | 24.9% | 10.8% | 4.8% | C |
| Zhejiang Longsheng 浙江龙盛 | ¥395亿 | 20.7x | 1.2x | 12.1% | 14.0% | 3.1% | C |
| Hoshine Silicon 合盛硅业 | ¥377亿 | — | 1.3x | 3.9% | 3.1% | 1.1% | D |
| Do-Fluoride New Materials 多氟多 | ¥368亿 | 54.7x | 4.2x | 62.5% | 8.2% | 5.9% | C |
| Sanmei 三美股份 | ¥305亿 | 14.3x | 3.6x | 20.7% | 30.7% | 12.6% | C |
| Cathay Biotech 凯赛生物 | ¥277亿 | 44.3x | 1.6x | 13.7% | 19.5% | 2.1% | C |
| Adisseo 安迪苏 | ¥249亿 | 18.9x | 1.3x | 14.0% | 9.3% | 4.5% | C |
| Hangzhou Oxygen Plant Group 杭氧股份 | ¥244亿 | 23.6x | 2.4x | 18.6% | 7.1% | 5.6% | C |
| Guangdong Hongda Holdings Group 广东宏大 | ¥215亿 | 22.1x | 3.0x | 10.8% | 8.4% | 7.5% | D |
| Xizang Gaozheng Civil Explosives 高争民爆 | ¥212亿 | 131.6x | 19.9x | -5.2% | 4.1% | 3.0% | D |
| Meihua Bio 梅花生物 | ¥206亿 | 9.5x | 1.3x | -0.4% | 5.4% | 4.0% | D |
Peers are listed by market cap, with this company highlighted. 同业按市值排列，本公司高亮显示。